NorthWest Biotherapeutics Inc (NWBO)

[Kaizenman]

Lykiri: Many thanks for posting this....

"Section 43 is a qualified exemption and a consideration of the public interest should be made. We have considered the public interest and cannot see any public interest argument that outweighs the commercial harm in alerting competitors to whether a rival product is trying to come onto the market or not. Examples of public interest arguments would be a major public health risk or a major procedural failure or irregularity.

I am very interested why they stated "... outweight the commercial harm in alerting competitors..." (above).

Peace!